Viewing StudyNCT06046794



Ignite Creation Date: 2024-05-06 @ 7:31 PM
Last Modification Date: 2024-10-26 @ 3:08 PM
Study NCT ID: NCT06046794
Status: RECRUITING
Last Update Posted: 2023-12-21
First Post: 2023-09-06

Brief Title: Efficacy of First-Line Gemcitabine Chemotherapy in GemCore Metastatic Pancreatic Adenocarcinoma Patients
Sponsor: Institut Paoli-Calmettes
Organization: Institut Paoli-Calmettes

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-02-01
Start Date Type: ESTIMATED
Primary Completion Date: 2027-11-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-11-01
Completion Date Type: ESTIMATED
First Submit Date: 2023-09-06
First Submit QC Date: September 19 2023
Study First Post Date: 2023-09-21
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-03
Last Update Post Date: 2023-12-21
Last Update Post Date Type: ACTUAL